Poorly differentiated, human liposarcoma LiSa-2 cell line response to the synthetic triterpenoid CDDO
Source: NCBI BioProject (ID PRJNA93767)

0 0

Project name: Homo sapiens
Description: Analysis of poorly differentiated LiSa-2 liposarcoma (LS) cells treated with the synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) or DMSO or a combination of CDDO and DMSO for up to 11 days. Synthetic triterpenoids exert a variety of actions, including anti-proliferative and proapoptotic effects, making them potentially useful in cancer therapy. Results provide insight into the pathogenesis of LS.Keywords: disease state analysis, CDDO effect, time courseOverall design: Temporal analysis of human liposarcoma cell line LiSa-2 subjected to treatment with a synthetic triterpenoid.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: CBCB, The University of Iowa
Release date: 2009-05-14
Last updated: 2005-11-21